Clarivate Plc(CLVT)

$1.93—

Chart

Clarivate Plc(CLVT)

NYSE

$1.93—

Chart Studio

CLVT(CLVT)

CLVT

Overview Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$0.19

Nov 4, 2026 · Reports before open

Revenue Estimate

$567M

FY2026E EPS$0.74

FY2027E EPS$0.77

Analyst Sentiment

Wall St. Consensus

Hold

20 analysts·High coverage

Score

6 Buy (30%)10 Hold (50%)4 Sell (20%)

Rating Breakdown

Strong Buy

00%

Buy

630%

Hold

1050%

Sell

420%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$2.00

+3.6%

Consensus

$2.00

+3.6%

Bull

$2.00

+3.6%

12-Month Target Range20 analysts

$2.00$2.00$2.00

Current $1.93Consensus

Current Price

$1.93

Upside to Consensus

$0.07

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+0.54%

EPS+3.34%

FY2028

Rev+1.57%

EPS+12.34%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E
Revenue Avg	$2.32B	$2.33B	$2.37B
Low	$2.31B	$2.31B	$2.37B
High	$2.33B	$2.35B	$2.38B
EBITDA Avg	$-76M	$-76M	$-77M
Low	$-76M	$-77M	$-78M
High	$-76M	$-76M	$-77M
EBIT Avg	$-609M	$-612M	$-622M
Low	$-612M	$-618M	$-623M
High	$-607M	$-607M	$-621M
Net Income Avg	$499M	$513M	$579M
Low	$486M	$509M	$578M
High	$512M	$517M	$581M
EPS Avg	$0.74	$0.77	$0.86
Low	$0.72	$0.76	$0.86
High	$0.76	$0.77	$0.86
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$567M	$578M	$576M	$581M	$569M	$584M	$604M	$610M
Low	$564M	$571M	$574M	$578M	$566M	$581M	$602M	$607M
High	$569M	$586M	$579M	$584M	$572M	$587M	$607M	$612M
EBITDA Avg	$-19M	$-19M	$-19M	$-19M	$-19M	$-19M	$-20M	$-20M
Low	$-19M	$-19M	$-19M	$-19M	$-19M	$-19M	$-20M	$-20M
High	$-18M	$-19M	$-19M	$-19M	$-19M	$-19M	$-20M	$-20M
EBIT Avg	$-149M	$-152M	$-151M	$-152M	$-149M	$-153M	$-159M	$-160M
Low	$-149M	$-154M	$-152M	$-153M	$-150M	$-154M	$-159M	$-161M
High	$-148M	$-150M	$-151M	$-152M	$-149M	$-153M	$-158M	$-159M
Net Income Avg	$113M	$121M	$109M	$117M	$124M	$147M	$134M	$134M
Low	$101M	$121M	$108M	$116M	$123M	$146M	$133M	$133M
High	$125M	$122M	$109M	$118M	$124M	$148M	$135M	$135M
EPS Avg	$0.18	$0.19	$0.17	$0.18	$0.19	$0.23	$0.21	$0.21
Low	$0.16	$0.19	$0.17	$0.18	$0.19	$0.23	$0.21	$0.21
High	$0.20	$0.19	$0.17	$0.18	$0.19	$0.23	$0.21	$0.21
Analysts (Rev / EPS)	1 / 2	1 / 2	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Jul 30, 2026Barclays

Clarivate price target lowered to $2 from $2.50 at Barclays

Target:$2.00

-7.0%from $2.15

Jul 7, 2026Barclays

Clarivate price target raised to $2.50 from $2.40 at Barclays

Target:$2.50

+2.5%from $2.44

Jan 8, 2026Goldman Sachs

Clarivate downgraded to Neutral from Buy at Goldman Sachs

Target:$3.60

+7.1%from $3.36

Dec 17, 2025Morgan Stanley

Clarivate downgraded to Underweight from Equal Weight at Morgan Stanley

Target:$3.00

-16.0%from $3.57

Oct 30, 2025Goldman Sachs

Clarivate price target lowered to $4.20 from $4.80 at Goldman Sachs

Target:$4.20

+25.2%from $3.35

Jun 13, 2023Oppenheimer

Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts

Target:$11.00

+22.4%from $8.98

Feb 6, 2023Morgan Stanley

Morgan Stanley Downgrades Clarivate to Equal-Weight, Raises Price Target to $12

Target:$12.00

+7.2%from $11.19

Apr 19, 2022Goldman Sachs

Goldman Sachs Maintains Buy on Clarivate, Lowers Price Target to $20

Target:$20.00

+17.2%from $17.07

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance